CAPAIA, MATTEO GINO LINO
 Distribuzione geografica
Continente #
EU - Europa 1.105
AS - Asia 150
NA - Nord America 78
SA - Sud America 19
AF - Africa 3
Totale 1.355
Nazione #
IT - Italia 1.073
US - Stati Uniti d'America 72
SG - Singapore 59
CN - Cina 42
VN - Vietnam 37
BR - Brasile 11
FI - Finlandia 9
FR - Francia 9
AR - Argentina 7
GB - Regno Unito 4
HK - Hong Kong 4
CA - Canada 3
MX - Messico 3
DE - Germania 2
RU - Federazione Russa 2
BD - Bangladesh 1
BH - Bahrain 1
CH - Svizzera 1
CL - Cile 1
ES - Italia 1
ET - Etiopia 1
HU - Ungheria 1
ID - Indonesia 1
IE - Irlanda 1
JO - Giordania 1
MA - Marocco 1
NP - Nepal 1
PH - Filippine 1
PK - Pakistan 1
PT - Portogallo 1
SI - Slovenia 1
SO - Somalia 1
TH - Thailandia 1
Totale 1.355
Città #
Genoa 471
Genova 378
Rapallo 111
Vado Ligure 107
Singapore 29
Ashburn 23
San Jose 21
Ho Chi Minh City 14
Helsinki 9
Beijing 8
Council Bluffs 8
Lauterbourg 8
Hanoi 6
Hong Kong 4
Santa Clara 4
City of London 2
Mexico City 2
Quận Bình Thạnh 2
São Paulo 2
Addis Ababa 1
Amman 1
Bangkok 1
Bismarck 1
Biên Hòa 1
Brasília 1
Budapest 1
Bắc Ninh 1
Catamarca 1
Chongqing 1
Comodoro Rivadavia 1
Curitiba 1
Dublin 1
Elmwood Park 1
Empalme San Vicente 1
Frankfurt am Main 1
Guangzhou 1
Hangzhou 1
Igaporã 1
Jakarta 1
Karachi 1
Kathmandu 1
La Plata 1
Las Anod 1
Leipzig 1
Lisbon 1
Ljubljana 1
Long An 1
Los Angeles 1
Maceió 1
Madrid 1
Manama 1
Manhuaçu 1
Medford 1
Milan 1
Montreal 1
New York 1
Ninh Bình 1
Orem 1
Ottawa 1
Palhoça 1
Paris 1
Pensacola 1
Petrolina 1
Quezon City 1
Quận Ninh Kiều 1
Raleigh 1
Rio das Ostras 1
Rome 1
Rostov-on-Don 1
San Miguel de Tucumán 1
Santa Fe 1
Santiago 1
Suzhou 1
São Bernardo do Campo 1
Thái Bình 1
Tláhuac 1
Toronto 1
Tétouan 1
Villa José León Suárez 1
Vĩnh Tường 1
Vũng Tàu 1
Walsall 1
Whitehall Township 1
Zurich 1
Ân Thi 1
Totale 1.275
Nome #
Adaptive phenotype drives resistance to androgen deprivation therapy in prostate cancer 199
A hnRNP K–AR-related signature reflects progression toward castration-resistant prostate cancer 188
Rivalutazione dell’etoposide come farmaco nelle forme avanzate di carcinoma prostatico 184
Role of Circulating Tumor Cells (CTC), Androgen Receptor Full Length (AR-FL) and Androgen Receptor Splice Variant 7 (AR-V7) in a Prospective Cohort of Castration-Resistant Metastatic Prostate Cancer Patients 147
A large SEER- based study of survival trends in patients with de novo metastatic prostate cancer 143
Etoposide and topoisomerase II inhibition for aggressive prostate cancer: Data from a translational study 136
The short-chain fatty acid butyrate decreases the regulatory function of human natural killer cells and promotes their maturation 119
Integrative Analysis of Periostin in Primary and Advanced Prostate Cancer 104
Real-world survival improvements in patients with newly diagnosed metastatic prostate cancer treated in the United States 97
Effect of SARS-CoV-2 vaccination on natural killer cell responses in multiple sclerosis 76
Totale 1.393
Categoria #
all - tutte 4.651
article - articoli 4.155
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.806


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202146 0 0 0 0 0 0 0 0 0 23 10 13
2021/2022116 7 2 10 11 7 11 4 21 7 13 10 13
2022/2023133 10 18 2 10 27 19 3 7 15 2 17 3
2023/2024139 4 4 0 15 6 27 3 16 10 8 10 36
2024/2025295 25 17 20 17 22 22 31 56 6 13 41 25
2025/2026420 64 4 36 51 63 24 69 25 40 44 0 0
Totale 1.393